AR and metastatic prostate carcinoma: Furthermore, while androgen receptor positivity increases in advanced and metastatic prostate cancers, oestrogen receptor ERα expression peaks for high‐grade prostatic intraepithelial neoplasia and is reduced for metastatic prostate cancer.48